𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer (ZO-FAST study)

✍ Scribed by N. Bundred; Campbell; R. Coleman; R. DeBoer; H. Edidtmann; A. Frassolati; A. Llombart; A. Monnier; P. Neven; R. Dias

Book ID
118624317
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
126 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effective inhibition of aromatase inhibi
Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole : ZO-FAST study results
✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the